title: Metabolism of 2-chloro-1,1-difluoroethene to glyoxylic and glycolic acid in rat hepatic microsomes.
abstract: The complete metabolic fate of the volatile anesthetic halothane is unclear since 2-chloro-1,1-diflurorethene (CDE), a reductive halothane metabolite, is known to readily release inorganic fluoride upon oxidation by cytochrome P-450. This study sought to clarify the metabolism of CDE by determining its metabolites and the roles of induce cytochrome P-450 forms in its metabolism. Upon incubation of [14C]CDE with rat hepatic microsomes, two major radioactive products were found which accounted for greater than 94% of the total metabolites. These compounds were determined to be the nonhalogenated compounds, glyoxylic and glycolic acids, which were formed in a ratio of approximately 1 to 2 of glyoxylic to glycolic acid. No other radioactive metabolites could be detected. Following incubation of CDE with hepatic microsomes isolated from rats treated with cytochrome P-450 inducers, measurement of fluoride release showed that phenobarbital induced CDE metabolism to the greatest degree at high CDE levels, isoniazid was the most effective inducer at low CDE concentrations, and beta-naphthoflavone was ineffective as an inducer. These results suggest that CDE biotransformation primarily involves the generation of an epoxide intermediate, which undergoes mechanisms of decay leading to total dehalogenation of the molecule, and that this metabolism is preferentially carried out by the phenobarbital- and ethanol-inducible forms of cytochrome P-450.
authors.affiliation: Department of Anesthesia, University of Iowa.
authors.forename: M T
authors.initials: MT
authors.lastname: Baker
authors.forename: M T
authors.initials: MT
authors.lastname: Vasquez
authors.forename: J N
authors.initials: JN
authors.lastname: Bates
authors.forename: C K
authors.initials: CK
authors.lastname: Chiang
mesh_terms: D000818:Animals; D001571:Benzoflavones / Q000494:pharmacology; D001711:Biotransformation; D017402:Chlorofluorocarbons; D002851:Chromatography, High Pressure Liquid; D002852:Chromatography, Ion Exchange; D003577:Cytochrome P-450 Enzyme System / Q000096:biosynthesis / Q000378:metabolism; D004790:Enzyme Induction / Q000187:drug effects; D006016:Glycolates / Q000378:metabolism*; D006038:Glyoxylates / Q000378:metabolism*; D006846:Hydrocarbons, Halogenated / Q000378:metabolism*; D066298:In Vitro Techniques; D007538:Isoniazid / Q000494:pharmacology; D008862:Microsomes, Liver / Q000201:enzymology / Q000378:metabolism*; D009249:NADP / Q000378:metabolism; D010634:Phenobarbital / Q000494:pharmacology; D011720:Pyrazoles / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D019324:beta-Naphthoflavone
chemical_list: D001571:Benzoflavones; D017402:Chlorofluorocarbons; D006016:Glycolates; D006038:Glyoxylates; D006846:Hydrocarbons, Halogenated; D011720:Pyrazoles; C031149:glycolic acid; C067537:2-chloro-1,1-difluoroethane; C031280:pyrazole; D009249:NADP; D019324:beta-Naphthoflavone; D003577:Cytochrome P-450 Enzyme System; C031150:glyoxylic acid; D007538:Isoniazid; D010634:Phenobarbital